-
Product Insights
Choroideremia - Drugs In Development, 2024
Empower your strategies with our Choroideremia – Drugs In Development, 2024 report and make more profitable business decisions. Choroideremia is an X-linked chorioretinal dystrophy characterized by the diffuse, progressive degeneration of the retinal pigment epithelium (RPE), photoreceptors, and choriocapillaris. It is caused by a mutation in the CHM gene. Symptoms include night blindness, difficulty in peripheral vision, lack of visual acuity, and loss of ability to see colors. The diagnosis of choroideremia can be done by characteristic fundus findings and family...
-
Product Insights
Limbal Stem Cell Deficiency (LSCD) - Drugs In Development, 2024
Empower your strategies with our Limbal Stem Cell Deficiency (LSCD) – Drugs In Development, 2024 report and make more profitable business decisions. Limbal Stem Cell Deficiency (LSCD) is characterized by a loss or deficiency of the stem cells in the limbus that are important for the regeneration of corneal epithelium and to the barrier function of the limbus. Due the loss of stem cells, the corneal epithelium is unable to repair and renew itself, resulting in in epithelial breakdown and persistent...
-
Product Insights
Meibomian Blepharitis - Drugs In Development, 2024
Empower your strategies with our Meibomian Blepharitis – Drugs In Development, 2024 report and make more profitable business decisions. Meibomian blepharitis or Meibomian gland dysfunction (MGD) is a condition that causes low-grade inflammation of the eyelids. It can also lead to obstruction of the oil glands in the eyelid. It is caused by high cholesterol and triglycerides, allergic conjunctivitis and other eye diseases, inflamed or damaged eyelid or cornea, bacterial infection, and autoimmune diseases like rosacea, lupus, rheumatoid arthritis, and Sjögren's...
-
Product Insights
Posterior Uveitis - Drugs In Development, 2024
Empower your strategies with our Posterior Uveitis – Drugs In Development, 2024 report and make more profitable business decisions. Posterior uveitis refers to intraocular inflammation in the vitreous, retina, or choroid. Chorioretinitis is an inflammation of the choroid (thin pigmented vascular coat of the eye) and retina of the eye. It is a form of posterior uveitis. Inflammation of these layers can lead to vision-threatening complications. The Posterior Uveitis drugs in development market research report provide comprehensive information on the therapeutics...
-
Product Insights
Viral Keratitis - Drugs In Development, 2024
Empower your strategies with our Viral Keratitis – Drugs In Development, 2024 report and make more profitable business decisions. Viral infection of the cornea is often caused by the herpes simplex virus (HSV) which frequently leaves what is called a 'dendritic ulcer'. Keratitis is a condition in which the eye's cornea, the clear dome on the front surface of the eye, becomes inflamed. The condition is often marked by moderate to intense pain and usually involves any of the following symptoms:...
-
Product Insights
Fuchs Endothelial Corneal Dystrophy (FECD) - Drugs In Development, 2024
Empower your strategies with our Fuchs Endothelial Corneal Dystrophy (FECD) – Drugs In Development, 2024 report and make more profitable business decisions. Fuchs endothelial corneal dystrophy (FECD) is characterized by progressive loss of corneal endothelial cells, thickening of Descement's membrane and deposition of extracellular matrix in the form of guttae. When the number of endothelial cells becomes critically low, the cornea swells and causes loss of vision. It affects the thin layer of cells that line the back part of the...
-
Product Insights
Optic Neuritis - Drugs In Development, 2024
Empower your strategies with our Optic Neuritis – Drugs In Development, 2024 report and make more profitable business decisions. Optic neuritis is an inflammation of the optic nerve, the bundle of nerve fibers that transmits visual information from the eye to the brain. Symptoms include pain, vision loss, dyschromatopsia, Uhthoff’s phenomenon, and flashing lights. Risk factors include age and genetic mutations. The Optic Neuritis drugs in development market research report provide comprehensive information on the therapeutics under development for Optic Neuritis,...
-
Product Insights
Optic Neuropathy - Drugs In Development, 2024
Empower your strategies with our Optic Neuropathy – Drugs In Development, 2024 report and make more profitable business decisions. Optic neuropathy is an inherited form of vision loss. Symptoms include eye pain or discomfort, numbness, tingling, and clouding of vision. Predisposing factors include age, smoking, alcohol, cancer treating drugs, stress related chemicals, some antibiotics, and cyanogens. The Optic Neuropathy drugs in development market research report provide comprehensive information on the therapeutics under development for Optic Neuropathy, complete with analysis by stage...
-
Product Insights
Rhino-Conjunctivitis - Drugs In Development, 2024
Empower your strategies with our Rhino-Conjunctivitis – Drugs In Development, 2024 report and make more profitable business decisions. Rhinitis is characterized by one or several of the following symptoms: nasal congestion, runny nose, post-nasal drip, sneezing, red eyes (conjunctivitis), and itching of the nose or eyes. It may be allergic or non-allergic. It is important to enact environmental control measures to avoid the allergens that are causing the problem. The Rhino-Conjunctivitis drugs in development market research report provide comprehensive information on...
-
Product Insights
Allergic Rhino-Conjunctivitis - Drugs In Development, 2024
Empower your strategies with our Allergic Rhino-Conjunctivitis – Drugs In Development, 2024 report and make more profitable business decisions. Allergic Rhino-Conjunctivitis is an allergen-induced inflammatory response mediated by IgE and most observed in children and most rare in children above 5 years and in adults. Allergens release by plants, herbs, pollens, animal dander, dust mites are common mediators. It is preferable to allergic rhinitis. The most common nasal symptoms are sneezing, irritability, itching, runny nose and non-nasal are redness, eye itching....
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.